Cancer Information Website Is a Resource for Patients, Family and Health Care
Providers for On-Line Research and Support Programs
SEATTLE, Wash., May 24 /PRNewswire/ -- A new website to help patients and
health care providers in their fight against cancer, oncologyknowledge.com,
was launched by Immunex Corporation (Nasdaq: IMNX) today at the annual meeting
of the American Society for Clinical Oncology in New Orleans.
"There is a wealth of information about cancer on the Internet, not all of
it reliable or comprehensive," said Michael Kleinberg, Pharm.D., vice
president, professional services. "With oncologyknowledge.com, we provide a
launching point from which people with cancer, their family members and their
health care providers can quickly access important and credible information
via the Internet."
Among the resources available to people researching cancer at the resource
center of ocologyknowledge.com are links to numerous leading non-profit cancer
research and treatment organizations, medical institutions, professional
journals and professional organizations.
The resource center has innovative and helpful tools for people involved
in the fight against prostate cancer. For cancer patients, there is a
private, interactive journal that allows them to keep track of doctor
appointments, blood counts, injections and contact information. Prostate
cancer patients may also access the EPIC (Empowered Patients in Control)(TM)
Program, designed to help late-stage prostate cancer patients and their
families cope with the disease.
There is a special feature for oncology nurses at
oncologyknowledge.com -- a chance for registered oncology nurses to win an
Oncology Nursing Society registration certificate for the 2001 Congress.
Immunex Corporation is a biopharmaceutical company dedicated to developing
immune system science to protect human health. The company's products offer
hope to patients with cancer, inflammatory and infectious diseases.
AHP owns a majority interest in Immunex. AHP is one of the world's
largest research-based pharmaceutical and health care products companies. It
is a leader in the discovery, development, manufacturing and marketing of
prescription drugs, including biotechnological and vaccine products, animal
health care products and over-the-counter medications.
NOTE: This news release contains forward-looking statements that involve
risks and uncertainties, including risks associated with clinical development,
regulatory approvals, product commercialization and other risks described from
time to time in the SEC reports filed by Immunex, including the most recently
filed Form 10-Q.
An electronic version of this news release -- as well as additional
information about Immunex of interest to investors, customers, future
employees and patients -- is available on the Immunex home page at
http://www.immunex.com.
SOURCE Immunex Corporation
 back to top
Related links:
http://www.immunex.com
Company News On-Call:
http://www.prnewswire.com/comp/434644.html or fax,
800-758-5804, ext. 434644
CONTACT:
media, Pam Rabe, 206-470-4131, or investors,
Mark Leahy, 206-389-4363, both of Immunex Corporation
|
